537 related articles for article (PubMed ID: 24865108)
1. Positron emission tomography image-guided drug delivery: current status and future perspectives.
Chakravarty R; Hong H; Cai W
Mol Pharm; 2014 Nov; 11(11):3777-97. PubMed ID: 24865108
[TBL] [Abstract][Full Text] [Related]
2. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
Koning GA; Krijger GC
Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
[TBL] [Abstract][Full Text] [Related]
3. Image guided therapy: the advent of theranostic agents.
Terreno E; Uggeri F; Aime S
J Control Release; 2012 Jul; 161(2):328-37. PubMed ID: 22626940
[TBL] [Abstract][Full Text] [Related]
4. Companion Diagnostic
Lee H; Gaddy D; Ventura M; Bernards N; de Souza R; Kirpotin D; Wickham T; Fitzgerald J; Zheng J; Hendriks BS
Theranostics; 2018; 8(9):2300-2312. PubMed ID: 29721081
[TBL] [Abstract][Full Text] [Related]
5. Nanotheranostics and image-guided drug delivery: current concepts and future directions.
Lammers T; Kiessling F; Hennink WE; Storm G
Mol Pharm; 2010 Dec; 7(6):1899-912. PubMed ID: 20822168
[TBL] [Abstract][Full Text] [Related]
6. Tumor Targeting Using Radiolabeled Antibodies for Image-Guided Drug Delivery.
Rijpkema M; Boerman OC; Oyen WJ
Curr Drug Targets; 2015; 16(6):625-33. PubMed ID: 25355181
[TBL] [Abstract][Full Text] [Related]
7. Targeted nanoparticles for image-guided treatment of triple-negative breast cancer: clinical significance and technological advances.
Miller-Kleinhenz JM; Bozeman EN; Yang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(6):797-816. PubMed ID: 25966677
[TBL] [Abstract][Full Text] [Related]
8. Molecular imaging of targeted therapies with positron emission tomography: the visualization of personalized cancer care.
Mammatas LH; Verheul HM; Hendrikse NH; Yaqub M; Lammertsma AA; Menke-van der Houven van Oordt CW
Cell Oncol (Dordr); 2015 Feb; 38(1):49-64. PubMed ID: 25248503
[TBL] [Abstract][Full Text] [Related]
9. Image-driven pharmacokinetics: nanomedicine concentration across space and time.
Brill DA; MacKay JA
Nanomedicine (Lond); 2015; 10(18):2861-79. PubMed ID: 26370694
[TBL] [Abstract][Full Text] [Related]
10. Image-Guided Drug Delivery with Single-Photon Emission Computed Tomography: A Review of Literature.
Chakravarty R; Hong H; Cai W
Curr Drug Targets; 2015; 16(6):592-609. PubMed ID: 25182469
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
Shokeen M; Fettig NM; Rossin R
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):267-77. PubMed ID: 18475250
[TBL] [Abstract][Full Text] [Related]
12. PET Radiopharmaceuticals for Personalized Medicine.
Sharma S
Curr Drug Targets; 2016; 17(16):1894-1907. PubMed ID: 27440185
[TBL] [Abstract][Full Text] [Related]
13. The role of imaging in targeted delivery of nanomedicine for cancer therapy.
Li P; Wang D; Hu J; Yang X
Adv Drug Deliv Rev; 2022 Oct; 189():114447. PubMed ID: 35863515
[TBL] [Abstract][Full Text] [Related]
14. Nanomedicines based drug delivery systems for anti-cancer targeting and treatment.
Jain V; Jain S; Mahajan SC
Curr Drug Deliv; 2015; 12(2):177-91. PubMed ID: 25146439
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
16. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
Chakravarty R; Goel S; Hong H; Chen F; Valdovinos HF; Hernandez R; Barnhart TE; Cai W
Nanomedicine (Lond); 2015; 10(8):1233-46. PubMed ID: 25955122
[TBL] [Abstract][Full Text] [Related]
17. [
Lamichhane N; Dewkar GK; Sundaresan G; Mahon RN; Zweit J
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28524076
[TBL] [Abstract][Full Text] [Related]
18. Image-guided and tumor-targeted drug delivery with radiolabeled unimolecular micelles.
Guo J; Hong H; Chen G; Shi S; Zheng Q; Zhang Y; Theuer CP; Barnhart TE; Cai W; Gong S
Biomaterials; 2013 Nov; 34(33):8323-8332. PubMed ID: 23932288
[TBL] [Abstract][Full Text] [Related]
19. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
[TBL] [Abstract][Full Text] [Related]
20. Receptor-targeted nanocarriers for therapeutic delivery to cancer.
Yu B; Tai HC; Xue W; Lee LJ; Lee RJ
Mol Membr Biol; 2010 Oct; 27(7):286-98. PubMed ID: 21028937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
